In a randomized , multicenter , @-week trial , liver transplant recipients ( > @ months and @ years post-transplant ) with recurrent HCV infection received cyclosporine ( n = @ ) or tacrolimus ( n = @ ) with a @-week course of pegylated interferon ( peg-IFN@a ) and ribavirin .